Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Lupus Ventures, also known as The Lupus Venture Fund, is a venture capital firm dedicated to addressing systemic lupus erythematosus (SLE) and related autoimmune conditions. Founded with the mission to enhance the standard of care for lupus patients, the firm is affiliated with the Lupus Research Alliance, which has invested over $284 million in lupus research. This affiliation strengthens Lupus Ventures' credibility and resource access, positioning it as a key player in the healthcare investment landscape.
The firm actively seeks to accelerate the development of new treatments and diagnostics that can significantly improve the lives of individuals living with lupus. By focusing on innovative healthcare solutions, Lupus Ventures aims to support groundbreaking projects that span various stages of development, from preclinical trials to commercial ventures. The firm operates with a commitment to advancing the understanding and treatment of lupus, making it a vital partner for startups in this sector.
Lupus Ventures invests in technologies that enhance the standard of care for lupus patients. The firm targets a range of sectors, including biotech, healthcare, digital health, and MedTech. It supports projects across all stages of development, including preclinical, Phase 1, 2, and 3 trials, as well as commercial ventures. This comprehensive approach allows Lupus Ventures to back a diverse array of company types, including biotech firms, pharmaceutical companies, diagnostics developers, and digital health startups.
The fund's investment strategy is centered on identifying and supporting innovations that can lead to improved treatment options and diagnostics for lupus and related autoimmune conditions. By providing funding at various stages, from pre-seed to Series C, Lupus Ventures is well-positioned to partner with startups that are developing cutting-edge solutions in the healthcare space.
Nishant Rastogi, Managing Director at Lupus Ventures, brings extensive experience in venture capital and a deep understanding of the healthcare landscape. His background includes working with various biotech firms and leading investments that focus on innovative healthcare solutions.
Albert T. Roy, President & CEO of the Lupus Research Alliance, plays a crucial role in guiding the strategic direction of Lupus Ventures. His leadership in the Lupus Research Alliance, which has invested over $284 million in lupus research, enhances the firm's credibility and resource access.
Startups interested in pitching to Lupus Ventures should visit their website at lupusventures.org for guidance on their preferred pitch format and any specific requirements. It is advisable to include detailed information about the technology, market potential, and development stage in the pitch deck.
What are Lupus Ventures' investment criteria?
Lupus Ventures focuses on technologies that enhance the standard of care for lupus patients. They invest in projects across all stages of development, including preclinical, Phase 1, 2, and 3 trials, as well as commercial ventures.
How can startups apply or pitch to Lupus Ventures?
Startups interested in pitching to Lupus Ventures can visit their website at lupusventures.org for more information on their investment focus and to find contact details.
What makes Lupus Ventures different from other investors?
Lupus Ventures is uniquely focused on systemic lupus erythematosus (SLE) and related autoimmune conditions, leveraging its affiliation with the Lupus Research Alliance to enhance its investment strategy and resource access.
What is the geographic scope of Lupus Ventures?
While specific geographic preferences are not detailed, Lupus Ventures is primarily focused on innovations that can improve lupus treatment, which may include companies from various locations that align with their mission.
What is the typical check size for investments?
Specific check sizes are not disclosed, but Lupus Ventures invests across multiple stages, from pre-seed to Series C, indicating a flexible investment approach.
What kind of post-investment involvement does Lupus Ventures have?
Lupus Ventures is likely to provide ongoing support and resources to portfolio companies, particularly in the healthcare sector, although specific details on their post-investment involvement are not provided.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.